Detalles de la búsqueda
1.
Identification of integrase inhibitor-related drug resistance mutations in newly diagnosed ART-naïve HIV patients.
Microb Pathog
; 181: 106217, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37385569
2.
Safety and efficacy of switching to elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate in treatment-experienced people with HIV: a multicenter cohort study.
AIDS Res Ther
; 20(1): 1, 2023 01 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36597160
3.
Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort.
HIV Med
; 23(8): 825-836, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35234328
4.
Incidence of hypertension in people with HIV who are treated with integrase inhibitors versus other antiretroviral regimens in the RESPOND cohort consortium.
HIV Med
; 23(8): 895-910, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35233903
5.
Comparison of weight gain after antiretroviral switch to integrase strand transfer inhibitor or tenofovir alafenamide-based therapy.
Infection
; 50(2): 407-412, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-34449049
6.
Safety and efficacy of pharmacotherapy containing INSTIs and chemotherapy drugs in people living with HIV and concomitant colorectal cancer.
AIDS Res Ther
; 19(1): 45, 2022 09 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36151562
7.
[Genetic Subtypes and Status of Transmitted Drug Resistance of HIV/AIDS Patients in Sichuan].
Sichuan Da Xue Xue Bao Yi Xue Ban
; 53(5): 851-856, 2022 Sep.
Artículo
en Zh
| MEDLINE | ID: mdl-36224688
8.
Pharmacokinetics of vaginally applied integrase inhibitors in macaques.
J Antimicrob Chemother
; 76(11): 2894-2901, 2021 10 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34423357
9.
Antiretroviral treatment outcomes among late HIV presenters initiating treatment with integrase inhibitors or protease inhibitors.
HIV Med
; 22(1): 47-53, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33047484
10.
Transmitted drug resistance to NRTIs and risk of virological failure in naïve patients treated with integrase inhibitors.
HIV Med
; 22(1): 22-27, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32964671
11.
Integrase inhibitors versus efavirenz combination antiretroviral therapies for TB/HIV coinfection: a meta-analysis of randomized controlled trials.
AIDS Res Ther
; 18(1): 25, 2021 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33933131
12.
The Integrase Inhibitors Dolutegravir and Raltegravir Exert Proadipogenic and Profibrotic Effects and Induce Insulin Resistance in Human/Simian Adipose Tissue and Human Adipocytes.
Clin Infect Dis
; 71(10): e549-e560, 2020 12 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-32166319
13.
Pregnancy and neonatal outcomes in women with HIV-1 exposed to integrase inhibitors, protease inhibitors and non-nucleoside reverse transcriptase inhibitors: an observational study.
Infection
; 48(2): 249-258, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-31893354
14.
Weight gain in antiretroviral therapy-naive HIV-1-infected patients starting a regimen including an integrase strand transfer inhibitor or darunavir/ritonavir.
Infection
; 48(2): 213-221, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-31713814
15.
Homeostatic model assessment for insulin resistance index trajectories in HIV-infected patients treated with different first-line antiretroviral regimens.
J Med Virol
; 91(11): 1937-1943, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31286527
16.
Prevalence of chronic kidney disease among HIV-1-infected patients receiving a combination antiretroviral therapy.
Clin Exp Nephrol
; 23(11): 1272-1279, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31327092
17.
First-line Raltegravir/Emtricitabine/Tenofovir Combination in Human Immunodeficiency Virus Type 2 (HIV-2) Infection: A Phase 2, Noncomparative Trial (ANRS 159 HIV-2).
Clin Infect Dis
; 67(8): 1161-1167, 2018 09 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-29590335
18.
Transmission of S230R integrase drug resistance mutation affecting second-generation integrase inhibitors in a French primary HIV-1 infected man.
J Antimicrob Chemother
; 78(7): 1802-1803, 2023 07 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37147875
19.
HIV treatment simplification to elvitegravir/cobicistat/emtricitabine/tenofovir disproxil fumarate (E/C/F/TDF) plus darunavir: a pharmacokinetic study.
AIDS Res Ther
; 14(1): 59, 2017 Nov 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29096670
20.
Integrase inhibitor (INI) genotypic resistance in treatment-naive and raltegravir-experienced patients infected with diverse HIV-1 clades.
J Antimicrob Chemother
; 70(11): 3080-6, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26311843